85 related articles for article (PubMed ID: 22982353)
1. Increased impact of a contraceptive vaginal ring with ethinyl estradiol and nestorone on C-reactive protein.
Rad M; Burggraaf J; Sitruk-Ware RL; de Kam ML; Cohen AF; Kluft C
Steroids; 2012 Nov; 77(13):1483-6. PubMed ID: 22982353
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.
Rad M; Kluft C; Ménard J; Burggraaf J; de Kam ML; Meijer P; Sivin I; Sitruk-Ware RL
Am J Obstet Gynecol; 2006 Jul; 195(1):72-7. PubMed ID: 16545330
[TBL] [Abstract][Full Text] [Related]
4. Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.
Archer DF; Thomas MA; Conard J; Merkatz RB; Creasy GW; Roberts K; Plagianos M; Blithe D; Sitruk-Ware R
Contraception; 2016 Jan; 93(1):58-64. PubMed ID: 26408374
[TBL] [Abstract][Full Text] [Related]
5. Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
Fraser IS; Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Tsong YY; Sivin I
Contraception; 2005 Jul; 72(1):40-5. PubMed ID: 15964291
[TBL] [Abstract][Full Text] [Related]
6. Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone/EE vs. a second-generation oral contraceptive containing levonorgestrel/EE.
Rad M; Burggraaf J; de Kam ML; Cohen AF; Kluft C
Contraception; 2012 Sep; 86(3):231-7. PubMed ID: 22445437
[TBL] [Abstract][Full Text] [Related]
7. Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study.
Simmons KB; Kumar N; Plagianos M; Roberts K; Hoskin E; Han L; Alami M; Creasy G; Variano B; Merkatz R
Contraception; 2018 Mar; 97(3):270-276. PubMed ID: 29097225
[TBL] [Abstract][Full Text] [Related]
8. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring.
Stifani BM; Plagianos M; Vieira CS; Merkatz RB
Contraception; 2018 May; 97(5):415-421. PubMed ID: 29269252
[TBL] [Abstract][Full Text] [Related]
10. Vaginal epithelial surface appearances in women using vaginal rings for contraception.
Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Lähteenmäki P; Elomaa K; Weisberg E; Nash HA
Contraception; 2000 Feb; 61(2):131-8. PubMed ID: 10802278
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction.
Merkatz RB; Plagianos M; Hoskin E; Cooney M; Hewett PC; Mensch BS
Contraception; 2014 Nov; 90(5):514-21. PubMed ID: 24993487
[TBL] [Abstract][Full Text] [Related]
12. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
Oddsson K; Leifels-Fischer B; Wiel-Masson D; de Melo NR; Benedetto C; Verhoeven CH; Dieben TO
Hum Reprod; 2005 Feb; 20(2):557-62. PubMed ID: 15539438
[TBL] [Abstract][Full Text] [Related]
13. Vaginal ring contraception.
Kerns J; Darney P
Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
[TBL] [Abstract][Full Text] [Related]
14. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
Barreiros FA; Guazzelli CA; Barbosa R; Torloni MR; Barbieri M; Araujo FF
Contraception; 2011 Aug; 84(2):155-9. PubMed ID: 21757057
[TBL] [Abstract][Full Text] [Related]
15. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
Gaussem P; Alhenc-Gelas M; Thomas JL; Bachelot-Loza C; Remones V; Ali FD; Aiach M; Scarabin PY
Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
[TBL] [Abstract][Full Text] [Related]
16. Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol.
Ballagh SA; Mishell DR; Jackanicz TM; Lacarra M; Eggena P
Contraception; 1994 Dec; 50(6):535-49. PubMed ID: 7705096
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
Akerlund M
Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
[TBL] [Abstract][Full Text] [Related]
18. Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study.
Battaglia C; Morotti E; Persico N; Battaglia B; Busacchi P; Casadio P; Paradisi R; Venturoli S
J Sex Med; 2014 Feb; 11(2):471-80. PubMed ID: 24299553
[TBL] [Abstract][Full Text] [Related]
19. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
[TBL] [Abstract][Full Text] [Related]
20. Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.
Jensen JT; Edelman AB; Chen BA; Archer DF; Barnhart KT; Thomas MA; Burke AE; Westhoff CL; Wan LS; Sitruk-Ware R; Kumar N; Variano B; Blithe DL
Contraception; 2018 May; 97(5):422-427. PubMed ID: 29409834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
